Seres Therapeutics, Inc. (MCRB)

15.84 +0.19 (+1.21%) USD  |  NASDAQ  |  Jan 12, 16:00
15.77 -0.07 (-0.44%) After-Hours: 20:00
More

Seres Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for MCRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. --
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --
Oragenics, Inc. --